Connect with us

Technology

Intel tries to take down Apple’s M1 chip with a flurry of benchmarks – Yahoo Finance Australia

Intel has shared a slew of benchmarks in a bid to downplay Apple’s M1 chip, although it’s not the resounding victory it appears to be at first.

Published

on

post featured image
ADVERTISEMENT

MALVERN, Pa., Feb. 07, 2021 (GLOBE NEWSWIRE) — Ocugen, Inc. (Nasdaq: OCGN), a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness diseases and developing a vaccine to fight COVID-19, today announced that it has entered into definitive agreements with healthcare-focused institutional investors for the sale of an aggregate of 3,000,000 shares of its common stock at a purchase price of $7.65 per share in a registered direct offering. The…

Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending